The Korean Journal of Medicine

  • 제84권2호
  • /
  • Pages.229-237
  • /
  • 2013
  • /
  • 1738-9364(pISSN)
  • /
  • 2289-0769(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

저 HDL 콜레스테롤혈증이 관상동맥 질환에 미치는 영향: 4년의 전향적 지역 기반 코호트 연구

Impact of Isolated Low HDL Cholesterolemia on the Risk of Coronary Artery Disease: A 4-Year Community-Based Prospective Study

  • 구보경 (서울대학교 의과대학 내과학교실, 서울특별시 보라매병원 내과) ;
  • 문민경 (서울대학교 의과대학 내과학교실, 서울특별시 보라매병원 내과)
  • Koo, Bo Kyung (Department of Internal Medicine, Seoul National University College of Medicine, Department of Internal Medicine, Boramae Medical Center) ;
  • Moon, Min Kyong (Department of Internal Medicine, Seoul National University College of Medicine, Department of Internal Medicine, Boramae Medical Center)
  • 투고 : 2012.12.17
  • 심사 : 2013.01.03
  • 발행 : 2013.02.01
⟨ 이전 논문 다음 논문 ⟩

초록

목적: 많은 역학 연구에서 낮은 HDL 콜레스테롤 농도가 관상동맥 질환의 위험을 높임이 보고되었으나, HDL 콜레스테롤이 직접적으로 관상동맥 질환 위험을 낮추는 역할을 하는지에 대해서는 아직 밝혀지지 않았다. 본 연구에서는 저 HDL 콜레스테롤혈증이 독립적으로 관상동맥 질환 발생을 높이는지를 전향적인 대규모 코호트에서 알아보고자 하였다. 방법: 안성, 안산 코호트는 한국인에서 만성 질환의 역학연구를 위해 수립된, 대규모의 지역기반 전향적 코호트로서, 2000-2001년에 기초조사를 시작하였고 2년마다 추적 조사를 시행하였다. 본 연구는 3기까지의 총 4년의 조사 결과를 대상으로 분석을 시행하였다. HDL 콜레스테롤의 역할에 대한 교란변수를 제거하기 위해 기초 조사 당시 당뇨병이 있거나, 이전 관상동맥 질환 병력이 있는 대상자는 연구에서 제외하였다. 결과: 총 8,438명의 연구 대상자의 0.8%에서 4년간의 추적관찰 기간 동안 관상동맥 질환이 발생하였다. 관상동맥 질환이 발생한 경우는 그렇지 않은 대상자에 비해 나이가 많고(p < 0.001), 체질량지수가 높았으며(p = 0.003) 고혈압(p = 0.005) 및 고중성지방혈증(p = 0.045) 유병률이 높았다. Cox 회귀분석 결과 고중성지방혈증은 유의하게 추적관찰 기간 동안의 관상동맥 질환 위험도를 높였다(hazard ratio, 1.822; 95% confidence interval, 1.029-3.225). 기저 HDL 콜레스테롤 농도는 기저 중성지방 혈중 농도와 유의한 상관관계에 있었으나(r = (남자) 0.404, (여자) 0.460; p < 0.001), 향후의 관상동맥 질환 위험도에 영향을 주지 못했다. 결론: 대규모 지역기반 코호트에서 저 HDL 콜레스테롤혈증은 독립적으로 4년 관상동맥 질환 위험을 높이지 않았다.

Background/Aims: We investigated the effect of an isolated low high-density lipoprotein (HDL) cholesterol level on the risk of coronary artery disease (CAD) in a prospective cohort. Methods: The Ansung-Ansan cohort was established for inclusion in a prospective, large-scale, community-based epidemiologic study to investigate chronic diseases in Korea. The data from a baseline survey performed from 2000 to 2001 and two subsequent prospective biennial surveys were analyzed. We included subjects without diabetes mellitus or a history of CAD at the baseline. Results: Among 8,438 total subjects, 0.8% reported newly developed CAD events during 4 years of follow-up. The subjects who experienced CAD events were significantly older (p < 0.001), had a higher body mass index (p = 0.003), and had a higher prevalence of hypertension (p = 0.005) and hypertriglyceridemia (p = 0.045) at the baseline. However, there was no significant difference in the baseline HDL cholesterol level between subjects with or without CAD events. Furthermore, although the baseline triglyceride level was significantly correlated with the baseline HDL cholesterol level (r = -0.404 in men and -0.460 in women; p < 0.001 in both), and Cox regression analysis showed that hypertriglyceridemia at the baseline was significantly associated with an increased hazard ratio for CAD events (hazard ratio, 1.822; 95% confidence interval, 1.029-3.225), low HDL cholesterolemia was not associated with a risk of CAD events. Conclusions: Low HDL cholesterolemia did not independently increase the subsequent 4 years' risk of CAD events in this community-based Korean cohort.

키워드

참고문헌

  1. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med 1977;62:707-714. https://doi.org/10.1016/0002-9343(77)90874-9
  2. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation 1989;79:8-15. https://doi.org/10.1161/01.CIR.79.1.8
  3. Di Angelantonio E, Sarwar N, Perry P, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009; 302:1993-2000. https://doi.org/10.1001/jama.2009.1619
  4. Wild S, Byrne CD. Time to rethink high-density lipoprotein? Heart 2008;94:692-694. https://doi.org/10.1136/hrt.2007.126326
  5. Vergeer M, Holleboom AG, Kastelein JJ, Kuivenhoven JA. The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis? J Lipid Res 2010;51:2058-2073. https://doi.org/10.1194/jlr.R001610
  6. Hansel B, Kontush A, Giral P, Bonnefont-Rousselot D, Chapman MJ, Bruckert E. One third of the variability in HDL-cholesterol level in a large dyslipidaemic population is predicted by age, sex and triglyceridaemia: the Paris La Pitie Study. Curr Med Res Opin 2006;22:1149-1160. https://doi.org/10.1185/030079906X104821
  7. Criqui MH, Wallace RB, Heiss G, Mishkel M, Schonfeld G, Jones GT. Cigarette smoking and plasma high-density lipoprotein cholesterol: the Lipid Research Clinics Program Prevalence Study. Circulation 1980;62(4 Pt 2):IV70-IV76.
  8. Rashid S, Genest J. Effect of obesity on high-density lipoprotein metabolism. Obesity (Silver Spring) 2007;15: 2875-2888. https://doi.org/10.1038/oby.2007.342
  9. Chahil TJ, Ginsberg HN. Diabetic dyslipidemia. Endocrinol Metab Clin North Am 2006;35:491-510. https://doi.org/10.1016/j.ecl.2006.06.002
  10. Hayek T, Azrolan N, Verdery RB, et al. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism: studies in transgenic mice. J Clin Invest 1993;92:1143-1152. https://doi.org/10.1172/JCI116683
  11. Tai ES, Emmanuel SC, Chew SK, Tan BY, Tan CE. Isolated low HDL cholesterol: an insulin-resistant state only in the presence of fasting hypertriglyceridemia. Diabetes 1999;48: 1088-1092. https://doi.org/10.2337/diabetes.48.5.1088
  12. Lim S, Shin H, Song JH, et al. Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007. Diabetes Care 2011;34:1323-1328. https://doi.org/10.2337/dc10-2109
  13. Cho NH, Jang HC, Choi SH, et al. Abnormal liver function test predicts type 2 diabetes: a community-based prospective study. Diabetes Care 2007;30:2566-2568. https://doi.org/10.2337/dc07-0106
  14. Choi SH, Kim TH, Lim S, Park KS, Jang HC, Cho NH. Hemoglobin A1c as a diagnostic tool for diabetes screening and new-onset diabetes prediction: a 6-year communitybased prospective study. Diabetes Care 2011;34:944-949. https://doi.org/10.2337/dc10-0644
  15. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-2752. https://doi.org/10.1161/CIRCULATIONAHA.105.169404
  16. Lamarche B, Despres JP, Moorjani S, Cantin B, Dagenais GR, Lupien PJ. Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Quebec Cardiovascular Study). Am J Cardiol 1995;75:1189-1195. https://doi.org/10.1016/S0002-9149(99)80760-7
  17. Castelli WP, Doyle JT, Gordon T, et al. HDL cholesterol and other lipids in coronary heart disease: the cooperative lipoprotein phenotyping study. Circulation 1977;55:767-772. https://doi.org/10.1161/01.CIR.55.5.767
  18. Brown BG, Zhao XQ, Chait A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001;345:1583-1592. https://doi.org/10.1056/NEJMoa011090
  19. Kontush A, Chapman MJ. Functionally defective highdensity lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev 2006;58:342-374. https://doi.org/10.1124/pr.58.3.1
  20. Boden WE, Probstfield JL, Anderson T, et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med 2011;365:2255-2267. https://doi.org/10.1056/NEJMoa1107579
  21. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P; CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001;286:180-187. https://doi.org/10.1001/jama.286.2.180
  22. Moriarity JT, Folsom AR, Iribarren C, Nieto FJ, Rosamond WD. Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 2000;10:136-143.
  23. Tunstall-Pedoe H, Vanuzzo D, Hobbs M, et al. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet 2000;355:688-700. https://doi.org/10.1016/S0140-6736(99)11181-4
  24. Kauma H, Savolainen MJ, Heikkila R, et al. Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors. Hum Genet 1996;97:156-162. https://doi.org/10.1007/BF02265258

피인용 문헌

  1. Metabolic syndrome and its related factors among Asian immigrant women in Korea vol.16, pp.3, 2014, https://doi.org/10.1111/nhs.12116
  2. 요양병원 입소 환자의 신체질량지수와 지질대사 vol.18, pp.4, 2013, https://doi.org/10.5762/kais.2017.18.4.267
  3. 사상체질에 따른 생활습관이 대사증후군 및 위험군에 미치는 영향 vol.29, pp.3, 2017, https://doi.org/10.7730/jscm.2017.29.3.232